Walleye Capital LLC acquired a new stake in Cue Health Inc. (NASDAQ:HLTH – Get Rating) during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor acquired 19,915 shares of the company’s stock, valued at approximately $64,000.
Other hedge funds and other institutional investors have also modified their holdings of the company. JPMorgan Chase & Co. boosted its stake in Cue Health by 84.5% during the 1st quarter. JPMorgan Chase & Co. now owns 10,264 shares of the company’s stock worth $66,000 after purchasing an additional 4,702 shares during the period. Prelude Capital Management LLC acquired a new position in Cue Health in the 1st quarter valued at about $70,000. Front Barnett Associates LLC purchased a new stake in Cue Health during the 1st quarter valued at approximately $71,000. Raymond James Financial Services Advisors Inc. acquired a new stake in Cue Health during the 1st quarter worth approximately $76,000. Finally, ProShare Advisors LLC purchased a new position in shares of Cue Health in the 2nd quarter valued at approximately $38,000. 37.87% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
Several brokerages recently weighed in on HLTH. Morgan Stanley decreased their price target on Cue Health from $10.00 to $8.00 and set an “equal weight” rating for the company in a report on Thursday, August 11th. The Goldman Sachs Group lowered their target price on shares of Cue Health from $7.00 to $6.00 and set a “buy” rating on the stock in a report on Friday, October 21st. Cowen reduced their price objective on shares of Cue Health from $9.00 to $7.00 and set an “outperform” rating for the company in a research report on Monday, November 14th. BTIG Research dropped their target price on Cue Health to $7.00 in a research report on Tuesday, November 15th. Finally, Cowen dropped their price objective on Cue Health from $9.00 to $7.00 and set an “outperform” rating on the stock in a report on Monday, November 14th.
Insider Buying and Selling
Cue Health Price Performance
Shares of NASDAQ:HLTH opened at $2.89 on Tuesday. The firm has a market capitalization of $431.86 million, a price-to-earnings ratio of -3.28 and a beta of 1.35. The business’s 50 day simple moving average is $3.41 and its 200-day simple moving average is $3.88. Cue Health Inc. has a 12 month low of $2.75 and a 12 month high of $16.20.
About Cue Health
Cue Health Inc, a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors.
- Get a free copy of the StockNews.com research report on Cue Health (HLTH)
- Three Ways To Win The Online Gambling Industry
- Santa Claus Rally? Here’s What Needs to Happen
- Is Ardelyx is A Buy After Slip in Early 2022
- Will the Return of Bob Iger Return the Magic to Disney Stock?
- Is Tesla A Bargain Now As It Trades At Two-Year Lows?
Receive News & Ratings for Cue Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cue Health and related companies with MarketBeat.com's FREE daily email newsletter.